2022 Trends and Strategic Insights for 2023
Including Insights from Special Feature:
Survey of Orthopedic Surgeons on “Life After Closing”
in Private Equity Deals
Gary W. Herschman, Health Care Mergers and Acquisitions attorney, in the firm’s Newark office, co-authored an article in the Journal of Orthopaedic Experience & Innovation, titled “Private Equity Partnerships with Orthopedic Groups: 2022 Trends and Strategic Insights for 2023 Including Insights from Special Feature: Survey of Orthopedic Surgeons on “Life After Closing” in Private Equity Deals.” The piece was also co-authored by Hector M. Torres, Managing Director within the global Healthcare Investment Banking practice of DC Advisory, and Dana Jacoby, Chief Executive Officer of Vector Medical Group, LLC.
Following is an abstract:
Orthopedics still very much remains an attractive area of investment for private equity because the demand for orthopedic care is high, yet the supply of orthopedic surgeons in the U.S. is relatively low. This supply and demand imbalance provides for long-term sustainable growth of orthopedic services within what remains a highly fragmented clinical specialty, thus bolstering investment interest from private equity firms seeking to form strategic partnerships with best-in-class orthopedic providers. Further, data from a recent survey of orthopedic surgeons who have partnered with private equity noted that “growth and long-term success of the clinical enterprise” were the main drivers of independent orthopedic groups pursuing private equity partnerships.
People
- Board of Directors / Member of the Firm